annual ROE:
373.63%+1240.31%(+143.11%)Summary
- As of today (August 19, 2025), ASND annual return on equity is 373.63%, with the most recent change of +1240.31% (+143.11%) on December 31, 2024.
- During the last 3 years, ASND annual ROE has risen by +418.27% (+936.98%).
- ASND annual ROE is now at all-time high.
Performance
ASND ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly ROE:
182.61%-8.90%(-4.65%)Summary
- As of today (August 19, 2025), ASND quarterly return on equity is 182.61%, with the most recent change of -8.90% (-4.65%) on June 1, 2025.
- Over the past year, ASND quarterly ROE has dropped by -69.68% (-27.62%).
- ASND quarterly ROE is now -64.34% below its all-time high of 512.04%, reached on March 31, 2024.
Performance
ASND quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
ASND ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +143.1% | -27.6% |
| 3 y3 years | +937.0% | +458.9% |
| 5 y5 years | +858.2% | +513.6% |
ASND ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +143.1% | -64.3% | +120.7% |
| 5 y | 5-year | at high | +143.1% | -64.3% | +120.7% |
| alltime | all time | at high | +143.1% | -64.3% | +120.7% |
ASND ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | 182.61%(-4.6%) |
| Mar 2025 | - | 191.51%(-4.3%) |
| Dec 2024 | 373.63%(-143.1%) | 200.12%(-5.8%) |
| Sep 2024 | - | 212.35%(-15.8%) |
| Jun 2024 | - | 252.29%(-50.7%) |
| Mar 2024 | - | 512.04%(-157.9%) |
| Dec 2023 | -866.68%(+809.1%) | -883.87%(+148.4%) |
| Sep 2023 | - | -355.88%(+81.2%) |
| Jun 2023 | - | -196.38%(+53.1%) |
| Mar 2023 | - | -128.26%(+31.1%) |
| Dec 2022 | -95.33%(+113.6%) | -97.84%(+50.3%) |
| Sep 2022 | - | -65.11%(+28.0%) |
| Jun 2022 | - | -50.88%(-8.5%) |
| Mar 2022 | - | -55.61%(+21.2%) |
| Dec 2021 | -44.64%(-20.7%) | -45.90%(-6.9%) |
| Sep 2021 | - | -49.29%(-19.8%) |
| Jun 2021 | - | -61.49%(+6.4%) |
| Mar 2021 | - | -57.79%(-5.3%) |
| Dec 2020 | -56.31%(+14.3%) | -61.04%(+9.7%) |
| Sep 2020 | - | -55.64%(+26.0%) |
| Jun 2020 | - | -44.15%(+24.5%) |
| Mar 2020 | - | -35.45%(-4.6%) |
| Dec 2019 | -49.28% | -37.14%(+15.1%) |
| Sep 2019 | - | -32.27%(-16.3%) |
| Jun 2019 | - | -38.54%(+7.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | -35.76%(-20.4%) |
| Dec 2018 | -56.33%(-17.1%) | -44.93%(-7.0%) |
| Sep 2018 | - | -48.31%(-13.0%) |
| Jun 2018 | - | -55.51%(-19.0%) |
| Mar 2018 | - | -68.57%(-6.4%) |
| Dec 2017 | -67.99%(+42.2%) | -73.26%(+1.5%) |
| Sep 2017 | - | -72.15%(-0.5%) |
| Jun 2017 | - | -72.50%(+18.4%) |
| Mar 2017 | - | -61.21%(-0.1%) |
| Dec 2016 | -47.81%(+21.9%) | -61.29%(-0.3%) |
| Sep 2016 | - | -61.47%(+34.9%) |
| Jun 2016 | - | -45.56%(+2.6%) |
| Mar 2016 | - | -44.40%(+41.9%) |
| Dec 2015 | -39.23%(-1.8%) | -31.29%(-10.1%) |
| Sep 2015 | - | -34.81%(-26.6%) |
| Jun 2015 | - | -47.43%(-14.3%) |
| Mar 2015 | - | -55.32%(-19.5%) |
| Dec 2014 | -39.96%(-139.6%) | -68.75%(+23.1%) |
| Sep 2014 | - | -55.84%(-926.0%) |
| Jun 2014 | - | 6.76%(-87.9%) |
| Mar 2014 | - | 56.03%(-17.1%) |
| Dec 2013 | 100.90%(-25.9%) | 67.61%(+225.8%) |
| Sep 2013 | - | 20.75%(>+9900.0%) |
| Jun 2013 | - | 0.00% |
| Dec 2012 | 136.21% | - |
FAQ
- What is Ascendis Pharma A/S annual return on equity?
- What is the all time high annual ROE for Ascendis Pharma A/S?
- What is Ascendis Pharma A/S annual ROE year-on-year change?
- What is Ascendis Pharma A/S quarterly return on equity?
- What is the all time high quarterly ROE for Ascendis Pharma A/S?
- What is Ascendis Pharma A/S quarterly ROE year-on-year change?
What is Ascendis Pharma A/S annual return on equity?
The current annual ROE of ASND is 373.63%
What is the all time high annual ROE for Ascendis Pharma A/S?
Ascendis Pharma A/S all-time high annual return on equity is 373.63%
What is Ascendis Pharma A/S annual ROE year-on-year change?
Over the past year, ASND annual return on equity has changed by +1240.31% (+143.11%)
What is Ascendis Pharma A/S quarterly return on equity?
The current quarterly ROE of ASND is 182.61%
What is the all time high quarterly ROE for Ascendis Pharma A/S?
Ascendis Pharma A/S all-time high quarterly return on equity is 512.04%
What is Ascendis Pharma A/S quarterly ROE year-on-year change?
Over the past year, ASND quarterly return on equity has changed by -69.68% (-27.62%)